SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-23-001091
Filing Date
2023-03-22
Accepted
2023-03-22 07:46:15
Documents
94
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2329404.htm   iXBRL 20-F 3299370
2 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 9255
3 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 9571
4 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4580
5 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 4684
6 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 3653
12 GRAPHIC image0.jpg GRAPHIC 21304
13 GRAPHIC image00004.jpg GRAPHIC 24910
  Complete submission text file 0001178913-23-001091.txt   12440240

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE blrx-20221231.xsd EX-101.SCH 98608
8 XBRL CALCULATION FILE blrx-20221231_cal.xml EX-101.CAL 60571
9 XBRL DEFINITION FILE blrx-20221231_def.xml EX-101.DEF 238763
10 XBRL LABEL FILE blrx-20221231_lab.xml EX-101.LAB 769987
11 XBRL PRESENTATION FILE blrx-20221231_pre.xml EX-101.PRE 400795
88 EXTRACTED XBRL INSTANCE DOCUMENT zk2329404_htm.xml XML 2694991
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35223 | Film No.: 23751435
SIC: 2834 Pharmaceutical Preparations